Xcout Intel
Clearblue
Clearblue is a globally recognized brand that manufactures and sells at-home pregnancy tests, ovulation tests, and fertility monitors.
Subscribe to see Clearblue’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Clearblue at a glance
Clearblue is a healthcare & diagnostics company headquartered in Switzerland. Its most recent funding round, Series A, raised $5.9M in March 2023. Xcout tracks 6 named people at Clearblue, including Monica Moore (Founder of “Fertile Health, LLC”).
Clearblue leadership
- Monica MooreFounder of “Fertile Health, LLC”
- William LedgerHead of Discipline of Obstetrics and Gynaecology of the Faculty of Medicine at the University of New South Wales , Director of Reproductive Medicine and Senior
- Kurt BarnhartVice Chair for Clinical Research and the Director of the Women’s Health Clinical Research Center
- Sarah BergaProfessor and Chair, Department of Obstetrics and Gynecology
- Suruchi S. ThakoreSurgical Center Medical Director
- Julie OliverGP with Special Interest (GPwSI) in Gynaecology
Clearblue funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5.9M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Clearblue competitors
A few of Clearblue's closest competitors — see the full list of competitors and alternatives →
Juno Diagnostics, Inc. operates a laboratory specializing in preimplantation genetic testing for patients undergoing fertility treatments and IVF. The company offers advanced genetic screenings to detect chromosomal abnormalities, single-gene disorders, and structural rearrangements in embryos.
Yourgene Health was a UK molecular diagnostics company that developed and commercialized genomic testing technologies, with a focus on reproductive health and non-invasive prenatal testing, including the IONA test. It served clinical laboratories, healthcare providers, and diagnostic partners; the company was acquired by Novacyt in 2023.
Hera Diagnostics Corp develops non-invasive, AI-powered diagnostic tools and molecular tests for women's health conditions, focusing on endometriosis detection and staging as well as point-of-care cervical cancer screening. The company provides practice-ready diagnostic solutions for OB-GYN, fertility, and clinical care workflows.
NX Prenatal Inc. is a private US-based molecular diagnostics and medical device company with corporate offices in Houston, Texas, and Lexington, Kentucky. It specializes in biomarker-based tests for women’s health and pregnancy outcomes.
Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the PreTRM test, is a blood-based biomarker assay specifically designed to predict the likelihood of spontaneous preterm birth in singleton pregnancies where no symptoms are yet present. Additionally, the company is cultivating a portfolio of potential tests for various other pregnancy-related conditions, such as preeclampsia, predicting time-to-birth at a molecular level, gestational diabetes mellitus, restricted fetal growth, stillbirth, and postpartum depression. Established in 2008, the organization's main operations are based in Salt Lake City, Utah.
Get Clearblue's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Clearblue in Xcout Intel
- 6 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access